CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...